Press Releases
-
Dec 6, 2018Nationwide availability for the first and only codeine-based, extended-release, oral-suspension cough/cold treatment in U.S. ...Dec 4, 2018Live Webcast at 9:00 am PT/12:00 pm ET Wednesday, December 5, 2018 ...Dec 3, 2018ENGLEWOOD, CO / ACCESSWIRE / December 3, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs, today announced two new appointments to the Company's board of directors. Ketan Mehta, Founder and Chief Executive Officer of Tris Pharma joined the board effective November 30, 2018. Ste...Nov 30, 2018Strategic Investment Positions Company with Approximately $19M in Cash ...Nov 27, 2018ENGLEWOOD, CO / ACCESSWIRE / November 27, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs, today announced that Josh Disbrow, Chairman and Chief Executive Officer, and David Green, Chief Financial Officer, will present at the 11th Annual LD Micro Main Event investor conference...Nov 15, 2018Fertility Preserved in Hypogonadal Men Taking Natesto, Based on Semen Analyses Conducted at Three-Month and Six-Month Timepoints...Nov 13, 2018Live Conference Call and Webcast Scheduled for 5:00 p.m. ET on November 15, 2018 Presentation of Interim Analysis by Dr. Ranjith Ramasamy, MD, Director of Reproductive Urology and Assistant Professor, Department of Urology, University of Miami ...Nov 7, 2018Company Posts Highest Ever Quarterly Revenue ...Nov 5, 2018Armistice Capital to Make $5M Strategic Investment in Conjunction with Tuzistra XR Acquisition to Accelerate Growth...Oct 31, 2018Live Conference Call and Webcast Scheduled for November 7, 2018, at 4:30 p.m. ET...